These data suggest that PCA3 improves the diagnostic sensitivity and specificity of PSA and that the combination of PCA3 with PSA analysis provides better overall performance in identification of PCa than serum PSA evaluation alone in the high-risk population. This evidence concerns the gene KLK3 and posterior cortical atrophy.